The burgeoning landscape of novel treatments for body management has seen the rise of both retatrutide and tirzepatide, both dual mechanism agonists targeting the GLP-1 and GIP receptors. While sharing a comparable https://abeliode822628.jasperwiki.com/7282900/retatrutide_vs_tirzepatide_a_comparative_analysis